Clinical Trial Update: Comparing Paroxetine and Duloxetine on Cardiovascular Measures [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing paroxetine and duloxetine on cardiovascular measures in patients with depressive symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (Cymbalta) (Duloxetine)
• Paroxetine (Paxil) (paroxetine)

Snippet

Sponsor: Duke University | Conditions: Depressive Symptoms | Phase 2, Phase 3 | Status: COMPLETED